These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28126911)

  • 1. Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations.
    Cogen JD; Oron AP; Gibson RL; Hoffman LR; Kronman MP; Ong T; Rosenfeld M
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
    Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD;
    JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum Of Pulmonary Exacerbation In Children And Adolescent With Cystic Fibrosis And Physicians' Practices: Experience From Tertiary Care Center From Lower-Middle Income Country.
    Aziz DA; Shahid S; Alam A; Aziz N; Iftikhar H; Mir F
    J Ayub Med Coll Abbottabad; 2021; 33(3):363-367. PubMed ID: 34487639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis.
    VanDevanter DR; Flume PA; Morris N; Konstan MW
    J Cyst Fibros; 2016 Nov; 15(6):783-790. PubMed ID: 27139161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of azithromycin in patients with cystic fibrosis.
    Samson C; Tamalet A; Thien HV; Taytard J; Perisson C; Nathan N; Clement A; Boelle PY; Corvol H
    Respir Med; 2016 Aug; 117():1-6. PubMed ID: 27492507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
    Davis CS; Faino AV; Onchiri F; Gibson RL; Merjaneh L; Ramsey BW; Rosenfeld M; Cogen JD
    Ann Am Thorac Soc; 2023 Jan; 20(1):75-82. PubMed ID: 36044723
    [No Abstract]   [Full Text] [Related]  

  • 8. Long term azithromycin therapy in patients with cystic fibrosis.
    Emiralioğlu N; Öztürk Z; Yalçın E; Doğru D; Özçelik U; Kiper N
    Turk J Pediatr; 2016; 58(1):34-40. PubMed ID: 27922234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
    Sanders DB; Solomon GM; Beckett VV; West NE; Daines CL; Heltshe SL; VanDevanter DR; Spahr JE; Gibson RL; Nick JA; Marshall BC; Flume PA; Goss CH;
    J Cyst Fibros; 2017 Sep; 16(5):592-599. PubMed ID: 28460885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary Exacerbations.
    Schechter MS; VanDevanter DR; Pasta DJ; Short SA; Morgan WJ; Konstan MW;
    Ann Am Thorac Soc; 2018 Feb; 15(2):225-233. PubMed ID: 29140726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role Of Long-Term Intermittent Use Of Oral Azithromycin On Pulmonary Exacerbations In Cystic Fibrosis Children.
    Aziz DA; Shahid S; Iftikhar H; Mir F
    J Ayub Med Coll Abbottabad; 2020; 32(4):429-434. PubMed ID: 33225638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
    West NE; Beckett VV; Jain R; Sanders DB; Nick JA; Heltshe SL; Dasenbrook EC; VanDevanter DR; Solomon GM; Goss CH; Flume PA;
    J Cyst Fibros; 2017 Sep; 16(5):600-606. PubMed ID: 28457954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.
    Dentice RL; Elkins MR; Middleton PG; Bishop JR; Wark PA; Dorahy DJ; Harmer CJ; Hu H; Bye PT
    Thorax; 2016 Feb; 71(2):141-7. PubMed ID: 26769016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving inpatient cystic fibrosis pulmonary exacerbation care: two success stories.
    Antos NJ; Quintero DR; Walsh-Kelly CM; Noe JE; Schechter MS
    BMJ Qual Saf; 2014 Apr; 23 Suppl 1():i33-i41. PubMed ID: 24608549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.
    Zobell JT; Young DC; Waters CD; Ampofo K; Stockmann C; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Jun; 48(6):525-37. PubMed ID: 23359557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
    Brownridge DJ; Zaidi STR
    J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes.
    Collaco JM; Green DM; Cutting GR; Naughton KM; Mogayzel PJ
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1137-43. PubMed ID: 20581166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Konstan MW; Butler SM; Schidlow DV; Morgan WJ; Julius JR; Johnson CA
    Pediatr Pulmonol; 1999 Oct; 28(4):248-54. PubMed ID: 10497373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.